{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Harbin Medisan Pharmaceutical Co., Ltd.
Harbin Medisan Stock Soars 10.01%, Hits Intraday High of CNY 14.83
Harbin Medisan Pharmaceutical Co., Ltd. saw a notable stock price increase on August 10, 2026, reaching an intraday high. The company has shown strong short-term momentum, with significant weekly and monthly gains, despite facing longer-term declines. Its market capitalization stands at CNY 2,450 million.
Harbin Medisan Stock Hits Day Low of CNY 9.82 Amid Price Pressure
Harbin Medisan Pharmaceutical Co., Ltd. faced a notable decline in its stock today, reflecting ongoing challenges. The company reported negative net profit and operating cash flow, alongside a decrease in net sales. With a market capitalization of CNY 1,626 million, it continues to struggle in the pharmaceuticals sector.
Harbin Medisan Stock Hits Day Low of CNY 10.90 Amid Price Pressure
Harbin Medisan Pharmaceutical Co., Ltd. saw a notable stock decline today, contrasting with the broader market. Despite a recent recovery, the company faces significant long-term challenges, including a negative net worth and declining financial metrics, with a market cap of CNY 1,626 million amid ongoing struggles in the sector.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
